Comparable Accuracy of Quantitative and Visual Analyses of [F]FDG PET/CT for the Detection of Lymph Node Metastases from Head and Neck Squamous Cell Carcinoma

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2023 Aug 26

PMID 37627898

Authors

Philippe dAbadie

Nicolas Michoux

Thierry Duprez

Sandra Schmitz

Michele Magremanne

Pascal Van Eeckhout

Olivier Gheysens

Affiliations

Soon will be listed here.

Abstract

Background: In head and neck squamous cell carcinoma (HNSCC), [F]FDG PET/CT is recommended for detecting recurrent disease and in the initial staging for evaluating distant metastases, but its use in detecting cervical lymph metastases remains unclear. The aim of this study is to evaluate and compare the diagnostic accuracy of [F]FDG-PET/CT using visual and semi-quantitative analyses for detecting the nodal involvement in HNSCC.

Methods: We analyzed consecutive patients who underwent a preoperative [F]FDG-PET/CT and neck dissection for HNSCC at our tertiary hospital. A blinded evaluation of the [F]FDG uptake in each neck level was performed using a semi-quantitative approach (SUVmax and SUVR) and a visual grading system (uptake superior to the internal jugular vein for grade 1 and superior to the liver for grade 2). Analyses were compared to the histological results.

Results: In our 211 patients, analyses demonstrated similar diagnostic accuracy using a semi-quantitative approach or a visual grading system. Regarding the visual grading system, [F]FDG-PET/CT detected nodal metastases with a specificity of 83% for lymph nodes classified as grade 1 and 98% for those classified as grade 2. The sensitivity was moderate, ranging from 60 to 63%.

Conclusions: [F]FDG PET/CT has a high specificity for detecting lymph node metastases in HNSCC and therefore must be considered in the nodal clinical staging.

References

Kim S, Pak K, Kim K . Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis. Am J Otolaryngol. 2018; 40(2):297-305. DOI: 10.1016/j.amjoto.2018.10.013. View

Tiwana M, Wu J, Hay J, Wong F, Cheung W, Olson R . 25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province. Oral Oncol. 2014; 50(7):651-6. DOI: 10.1016/j.oraloncology.2014.03.009. View

Vigneswaran N, Williams M . Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am. 2014; 26(2):123-41. PMC: 4040236. DOI: 10.1016/j.coms.2014.01.001. View

Samolyk-Kogaczewska N, Sierko E, Dziemianczyk-Pakiela D, Nowaszewska K, Lukasik M, Reszec J . Usefulness of Hybrid PET/MRI in Clinical Evaluation of Head and Neck Cancer Patients. Cancers (Basel). 2020; 12(2). PMC: 7072319. DOI: 10.3390/cancers12020511. View

Machiels J, Leemans C, Golusinski W, Grau C, Licitra L, Gregoire V . Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; 31(11):1462-1475. DOI: 10.1016/j.annonc.2020.07.011. View

Kim S, Friedman K, Patel S, Hagiwara M . Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer. AJR Am J Roentgenol. 2016; 207(2):248-56. PMC: 5756667. DOI: 10.2214/AJR.16.16265. View

Surti S, Kuhn A, Werner M, Perkins A, Kolthammer J, Karp J . Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med. 2007; 48(3):471-80. View

Driessen D, Dijkema T, Weijs W, Takes R, Pegge S, Zamecnik P . Novel Diagnostic Approaches for Assessment of the Clinically Negative Neck in Head and Neck Cancer Patients. Front Oncol. 2021; 10:637513. PMC: 7901951. DOI: 10.3389/fonc.2020.637513. View

Kyzas P . Management of the cN0 neck in early oral cancer: time to revise the guidance?. Br J Oral Maxillofac Surg. 2021; 59(4):387-388. DOI: 10.1016/j.bjoms.2020.10.005. View

10.

Kyzas P, Evangelou E, Denaxa-Kyza D, Ioannidis J . 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008; 100(10):712-20. DOI: 10.1093/jnci/djn125. View

11.

Hoang J, Vanka J, Ludwig B, Glastonbury C . Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: tips, traps, and a systematic approach. AJR Am J Roentgenol. 2012; 200(1):W17-25. DOI: 10.2214/AJR.12.8960. View

12.

Hamoir M, Schmitz S, Gregoire V . The role of neck dissection in squamous cell carcinoma of the head and neck. Curr Treat Options Oncol. 2014; 15(4):611-24. DOI: 10.1007/s11864-014-0311-7. View

13.

de Bree R, Takes R, Castelijns J, Medina J, Stoeckli S, Mancuso A . Advances in diagnostic modalities to detect occult lymph node metastases in head and neck squamous cell carcinoma. Head Neck. 2014; 37(12):1829-39. DOI: 10.1002/hed.23814. View

14.

Johnson D, Burtness B, Leemans C, Lui V, Bauman J, Grandis J . Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020; 6(1):92. PMC: 7944998. DOI: 10.1038/s41572-020-00224-3. View

15.

Boellaard R . Standards for PET image acquisition and quantitative data analysis. J Nucl Med. 2009; 50 Suppl 1:11S-20S. DOI: 10.2967/jnumed.108.057182. View

16.

Sun R, Tang X, Yang Y, Zhang C . (18)FDG-PET/CT for the detection of regional nodal metastasis in patients with head and neck cancer: a meta-analysis. Oral Oncol. 2015; 51(4):314-20. DOI: 10.1016/j.oraloncology.2015.01.004. View

17.

Bauwens L, Baltres A, Fiani D, Zrounba P, Buiret G, Fleury B . Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma. Radiother Oncol. 2021; 157:122-129. DOI: 10.1016/j.radonc.2021.01.028. View

18.

Chen C, Lin J, Chen K . Lymph node ratio as a prognostic factor in head and neck cancer patients. Radiat Oncol. 2015; 10:181. PMC: 4554293. DOI: 10.1186/s13014-015-0490-9. View

19.

Roh J, Park J, Kim J, Lee J, Cho K, Choi S . 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study. Radiology. 2014; 271(1):153-61. DOI: 10.1148/radiol.13131470. View

20.

Nakagawa T, Yamada M, Suzuki Y . 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles. J Nucl Med. 2008; 49(7):1053-9. DOI: 10.2967/jnumed.107.049718. View